title: Therapeutic approaches to muscular dystrophy.
abstract: Muscular dystrophies are a heterogeneous group of genetic disorders characterized by muscle weakness and wasting. Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular dystrophy, and although the molecular mechanisms of the disease have been extensively investigated since the discovery of the gene in 1986, there is currently no effective treatment. However, new gene-based therapies have recently emerged with particular noted advances in using conventional gene replacement strategies, RNA-based technology and pharmacological approaches. While the proof of principle has been demonstrated in animal models, several clinical trials have recently been undertaken to investigate the feasibility of these strategies in patients. In particular, antisense-mediated exon skipping has shown encouraging results and holds promise for the treatment of dystrophic muscle. Here, we summarize the recent progress in therapeutic approaches to muscular dystrophies, with an emphasis on gene therapy and exon skipping for DMD.
authors: MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
authors: Aurélie
authors: A
authors: Goyenvalle
authors: Jane T
authors: JT
authors: Seto
authors: Kay E
authors: KE
authors: Davies
authors: Jeffrey
authors: J
authors: Chamberlain
mesh_terms: D016189:Dystrophin / Q000235:genetics; D005091:Exons / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D009136:Muscular Dystrophies / Q000235:genetics / Q000628:therapy*
chemical_list: D016189:Dystrophin